232 related articles for article (PubMed ID: 24371048)
41. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
42. Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms.
Galli A; Lai A; Corvasce S; Saladini F; Riva C; Dehò L; Caramma I; Franzetti M; Romano L; Galli M; Zazzi M; Balotta C
J Gen Virol; 2008 Dec; 89(Pt 12):3119-3125. PubMed ID: 19008401
[TBL] [Abstract][Full Text] [Related]
43. Molecular mechanisms behind the generation of pro-oncogenic HIV-1 matrix protein p17 variants.
Zani A; Messali S; Bugatti A; Uggeri M; Rondina A; Sclavi L; Caccuri F; Caruso A
J Gen Virol; 2024 Apr; 105(4):. PubMed ID: 38687324
[TBL] [Abstract][Full Text] [Related]
44. HIV-1 Mutation and Recombination Rates Are Different in Macrophages and T-cells.
Cromer D; Schlub TE; Smyth RP; Grimm AJ; Chopra A; Mallal S; Davenport MP; Mak J
Viruses; 2016 Apr; 8(4):118. PubMed ID: 27110814
[TBL] [Abstract][Full Text] [Related]
45. Circulation of HIV-1 Multiple Complexity Recombinant Forms Among Female Sex Workers Recently Infected with HIV-1 in Thailand.
Saeng-Aroon S; Loket R; Plipat T; Lumyai S; Chu PY; Sangkitporn S; Nakayama EE; Takeda N; Shioda T; Motomura K
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):694-701. PubMed ID: 26892382
[TBL] [Abstract][Full Text] [Related]
46. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.
Gianella S; Delport W; Pacold ME; Young JA; Choi JY; Little SJ; Richman DD; Kosakovsky Pond SL; Smith DM
J Virol; 2011 Aug; 85(16):8359-67. PubMed ID: 21632754
[TBL] [Abstract][Full Text] [Related]
47. Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates.
Knops E; Däumer M; Awerkiew S; Kartashev V; Schülter E; Kutsev S; Brakier-Gingras L; Kaiser R; Pfister H; Verheyen J
J Antimicrob Chemother; 2010 Jul; 65(7):1472-6. PubMed ID: 20430786
[TBL] [Abstract][Full Text] [Related]
48. Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor.
Ho SK; Perez EE; Rose SL; Coman RM; Lowe AC; Hou W; Ma C; Lawrence RM; Dunn BM; Sleasman JW; Goodenow MM
AIDS; 2009 Aug; 23(13):1631-40. PubMed ID: 19625947
[TBL] [Abstract][Full Text] [Related]
49. Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.
Diallo K; Zheng DP; Rottinghaus EK; Bassey O; Yang C
AIDS Res Hum Retroviruses; 2015 May; 31(5):564-75. PubMed ID: 25582324
[TBL] [Abstract][Full Text] [Related]
50. Near full-length genomic analysis of a novel subtype A1/C recombinant HIV type 1 isolate from Canada.
Ntemgwa M; Toni TD; Brenner BG; Routy JP; Moisi D; Oliveira M; Wainberg MA
AIDS Res Hum Retroviruses; 2008 Apr; 24(4):655-9. PubMed ID: 18366312
[TBL] [Abstract][Full Text] [Related]
51. Accurately measuring recombination between closely related HIV-1 genomes.
Schlub TE; Smyth RP; Grimm AJ; Mak J; Davenport MP
PLoS Comput Biol; 2010 Apr; 6(4):e1000766. PubMed ID: 20442872
[TBL] [Abstract][Full Text] [Related]
52. The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V.
Knops E; Kemper I; Schülter E; Pfister H; Kaiser R; Verheyen J
AIDS; 2010 Mar; 24(5):779-81. PubMed ID: 20139751
[TBL] [Abstract][Full Text] [Related]
53. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
Stoddard MB; Li H; Wang S; Saeed M; Andrus L; Ding W; Jiang X; Learn GH; von Schaewen M; Wen J; Goepfert PA; Hahn BH; Ploss A; Rice CM; Shaw GM
mBio; 2015 Feb; 6(2):e02518. PubMed ID: 25714714
[TBL] [Abstract][Full Text] [Related]
54. Phylogenetic Analysis of Ethiopian HIV-1 Subtype C Near Full-Length Genomes Reveals High Intrasubtype Diversity and a Strong Geographical Cluster.
Amogne W; Bontell I; Grossmann S; Aderaye G; Lindquist L; Sönnerborg A; Neogi U
AIDS Res Hum Retroviruses; 2016 May; 32(5):471-4. PubMed ID: 26881451
[TBL] [Abstract][Full Text] [Related]
55. Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping.
Robinson LH; Gale CV; Kleim JP
J Virol Methods; 2002 Jul; 104(2):147-60. PubMed ID: 12088824
[TBL] [Abstract][Full Text] [Related]
56. Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men.
Simonetti FR; Lai A; Monno L; Binda F; Brindicci G; Punzi G; Bozzi G; Violin M; Galli M; Zazzi M; Angarano G; Balotta C
Infect Genet Evol; 2014 Apr; 23():176-81. PubMed ID: 24602697
[TBL] [Abstract][Full Text] [Related]
57. High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.
Nedellec R; Herbeck JT; Hunt PW; Deeks SG; Mullins JI; Anton ED; Reeves JD; Mosier DE
AIDS Res Hum Retroviruses; 2017 Mar; 33(3):234-245. PubMed ID: 27604829
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption.
Li JZ; Christensen JA; Wang H; Spritzler J; Kuritzkes DR;
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):19-22. PubMed ID: 22732468
[TBL] [Abstract][Full Text] [Related]
59. The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.
Liu Y; Jia L; Su B; Li H; Li Z; Han J; Zhang Y; Zhang T; Li T; Wu H; Li J; Li L
AIDS Res Hum Retroviruses; 2020 May; 36(5):440-449. PubMed ID: 31766855
[TBL] [Abstract][Full Text] [Related]
60. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.
Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K
Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
